Cellanome

Palo Alto, CA · Founded 2020 · Biotech · Private

Live-cell imaging platform integrated with single-cell transcriptomics and CellCage cell-tracking technology

Claim this profile

Follows are private to you and power your alerts

Updated · cellanome.com

Sector
Biotech
Headquarters
Palo Alto, CA
Founded
2020
Latest Form D
$75.9M, Jun 2026
Total capital
$279M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$279M
5 Form D · last Jun 2026
4 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
14
26 pending · first 2023
Rank in peer group#18 of 342

Capital timeline

202120222023202420252026FEDERAL ↑EQUITY ↓Cumulative $279M1st Form D$2M3rd Form D$30M4th Form D$150M5th Form D$75.9M
202120222023202420252026FEDERAL ↑EQUITY ↓Cumulative $279M4th Form D$150M

Latest events

  • Private capital raisedForm D · SEC · 5th filing$75.9M
  • Private capital raisedForm D · SEC · 4th filing$150M
  • Private capital raisedForm D · SEC · 3rd filing$30M
  • Private capital raisedForm D · SEC · 2nd filing$21M
  • Private capital raisedForm D · SEC · 1st filing$2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 342 peers

Line = median

Biotech · Platform

  • Granted patents#18 · top 5%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Ali AgahExecutive Officer, DirectorNamed in SEC Form D filings
  • Jay FlatleyDirectorNamed in SEC Form D filings
  • Kazutaka OhnoExecutive OfficerNamed in SEC Form D filings
  • Mehdi KhodadadExecutive OfficerNamed in SEC Form D filings
  • Mostafa Kumar RonaghiDirectorNamed in SEC Form D filings
  • Omead Kumar OstadanDirectorNamed in SEC Form D filings
Show all 10 people
  • Rowan ChapmanDirectorNamed in SEC Form D filings
  • Sandesh PatnamDirectorNamed in SEC Form D filings
  • Sue McGrathExecutive OfficerNamed in SEC Form D filings
  • Tarun KhuranaExecutive OfficerNamed in SEC Form D filings

What it has protected

USPTO · 14 granted of 40
  • GrantedFlow CellUSPTOUS D1,148,123
  • PendingCell Sorting And Selection Using Degradable HydrogelsUSPTOApplication 19429978
  • GrantedFlow CellUSPTOUS D1,146,065
Show all 40 patent records

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .